Literature DB >> 15771445

Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.

Paola Gilli1, Gastone Gilli, Pier Andrea Borea, Katia Varani, Angelo Scatturin, Alessandro Dalpiaz.   

Abstract

Drug-receptor binding thermodynamics has proved to be a valid tool for pharmacological and pharmaceutical characterization of molecular mechanisms of receptor-recognition phenomena. The large number of membrane receptors so far studied has led to the discovery of enthalpy-entropy compensation effects in drug-receptor binding and discrimination between agonists and antagonists by thermodynamic methods. Since a single thermodynamic study on cytoplasmic receptors was known, this paper reports on binding thermodynamics of estradiol, ORG2058, and R1881 bound to estrogen, progesterone, and androgen steroid/nuclear receptors, respectively, as determined by variable-temperature binding constant measurements. The binding at 25 degrees C appears enthalpy/entropy-driven (-53.0 </= DeltaG degrees </= -48.6, -34.5 </= DeltaH degrees </= -19.9 kJ/mol, 0.057 </= DeltaS degrees </= 0.111, and -2.4 </= DeltaC(p) degrees </= -1.7 kJ mol(-1) K(-1)) and is interpreted in terms of hydrophobic and hydrogen-bonded specific interactions. Results obtained for cytoplasmic receptors are extensively compared with those known for typical membrane receptors, in particular the adenosine A(1) receptor, to investigate the thermodynamic bases of drug-receptor binding from the most general point of view.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771445     DOI: 10.1021/jm040842z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency.

Authors:  Aiming Sun; Terry W Moore; Jillian R Gunther; Mi-Sun Kim; Eric Rhoden; Yuhong Du; Haian Fu; James P Snyder; John A Katzenellenbogen
Journal:  ChemMedChem       Date:  2011-03-01       Impact factor: 3.466

2.  Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.

Authors:  Amanda B Witte; Christine M Timmer; Jeremy J Gam; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  Biomacromolecules       Date:  2012-01-18       Impact factor: 6.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.